BackNeuronetics Overview

Neuronetics Long Term Debt

Track Neuronetics's long-term debt ($81M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$81.38M
↑ 8.02% YoYΔ $6.04M vs prior year quarter

Peer trimmed avg / median

Loading

Neuronetics Long Term Debt History

Loading

Neuronetics vs. peers: Long Term Debt Comparison

Loading

Neuronetics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Neuronetics (STIM) FAQ

Neuronetics (STIM) currently reports a long-term debt of $81M as of June 2026. That compares with $75M in the prior-year period — up 8.0% year over year. Use the charts on this page to explore Neuronetics's long-term debt history and peer comparisons.

Neuronetics's long-term debt increased from $75M to $81M — a 8.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neuronetics reported $81M in long-term debt as of June 2026. That compares with $75M in the prior-year period — up 8.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $81M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neuronetics, and consider following STIM for alerts when major investors trade the stock.

Neuronetics is classified in the Healthcare sector. On long-term debt, it currently shows $81M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing STIM with unrelated industries.